Investigation of FOXM1 as a potential new target for melanoma

A Miyashita, S Fukushima, S Nakahara, J Yamashita… - PloS one, 2015 - journals.plos.org
Recent studies have shown that immunotherapies and molecular targeted therapies are
effective for advanced melanoma. Non-antigen-specific immunotherapies such as …

Etlingera elatior Extract promotes cell death in B16 melanoma cells via down-regulation of ERK and Akt signaling pathways

A Krajarng, M Chulasiri, R Watanapokasin - BMC complementary and …, 2017 - Springer
Abstract Background Torch ginger (Etlingera elatior, EE) is a ginger plant that found in
Southeast Asia. Previous study showed its flowers and leaves composed of several …

IQ motif containing GTPase activating proteins (IQGAPs), A-kinase anchoring proteins (AKAPs) and kinase suppressor of ras proteins (KSRs) in scaffolding oncogenic …

T Mohapatra, M Dixit - ACS omega, 2022 - ACS Publications
Scaffolding proteins colocalize interacting partners on their surface and facilitate complex
formation. They have multiple domains and motifs, which provide binding sites for various …

miR-410-3p is induced by vemurafenib via ER stress and contributes to resistance to BRAF inhibitor in melanoma

TM Grzywa, K Klicka, W Paskal, J Dudkiewicz… - PLoS …, 2020 - journals.plos.org
Despite significant development of melanoma therapies, death rates remain high.
MicroRNAs, controlling posttranscriptionally gene expression, play role in development of …

Bioinformatics analysis of rheumatoid arthritis tissues identifies genes and potential drugs that are expressed specifically

Q He, H Ding - Scientific Reports, 2023 - nature.com
Studies have implicated necroptosis mechanisms in orthopaedic-related diseases, since
necroptosis is a unique regulatory cell death pattern. However, the role of Necroptosis …

A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC

N Dompe, C Klijn, SA Watson, K Leng, J Port… - PLoS …, 2018 - journals.plos.org
Mutant KRAS represents one of the most frequently observed oncogenes in NSCLC, yet no
therapies are approved for tumors that express activated KRAS variants. While there is …

Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA

A Marranci, R D'Aurizio, S Vencken, S Mero… - RNA biology, 2019 - Taylor & Francis
Here we present miR-CATCHv2. 0, an implemented experimental method that allows the
identification of the microRNA species directly bound to an RNA of interest. After cross …

Cell cycle‐tailored targeting of metastatic melanoma: Challenges and opportunities

NK Haass, B Gabrielli - Experimental Dermatology, 2017 - Wiley Online Library
The advent of targeted therapies of metastatic melanoma, such as MAPK pathway inhibitors
and immune checkpoint antagonists, has turned dermato‐oncology from the “bad guy” to the …

[HTML][HTML] The anti-apoptotic BAG3 protein is involved in BRAF inhibitor resistance in melanoma cells

L Guerriero, G Palmieri, M De Marco, A Cossu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
BAG3 protein, a member of BAG family of co-chaperones, has a pro-survival role in several
tumour types. BAG3 anti-apoptotic properties rely on its characteristic to bind several …

Electrotransfer of plasmid DNA encoding an anti-mouse endoglin (CD105) shRNA to B16 melanoma tumors with low and high metastatic potential results in …

T Dolinsek, G Sersa, L Prosen, M Bosnjak, M Stimac… - Cancers, 2015 - mdpi.com
Endoglin overexpression is associated with highly proliferative tumor endothelium and also
with some tumors, including melanoma. Its targeting has anti-tumor effectiveness, which can …